Form 8-K - Current report:
SEC Accession No. 0000950170-24-036847
Filing Date
2024-03-27
Accepted
2024-03-27 09:23:32
Documents
13
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgx-20240327.htm   iXBRL 8-K 40421
2 EX-99.1 mgx-ex99_1.htm EX-99.1 106199
3 GRAPHIC img133734535_0.jpg GRAPHIC 111350
  Complete submission text file 0000950170-24-036847.txt   430645

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20240327.xsd EX-101.SCH 26950
16 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20240327_htm.xml XML 5109
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41949 | Film No.: 24786078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)